Targeted and gentle treatment of tumors: percutaneous electrical tumor therapy (PET)
Percutaneous electrical tumor therapy (PET) is a targeted and gentle method based on the findings of the Italian biophysicist Luigi Galvani (1737 – 1798). By means of two charged electrodes, a direct current is supplied to the tumor tissues that are to be treated.
The resistance is lower in the cancer cells than in healthy tissue cells. This means that the electrical conductivity is higher in tumor cells than in healthy tissue cells due to the degenerating condition of the cell.
These physicochemical property uses gentle electrical percutaneous tumor therapy (PET). Healthy tissues or organs are not damaged due to their higher resistance compared to the diseased tissue.
Dr. Siebenhüner commented on the physiological process of percutaneous electrical tumor therapy (PET) for the targeted and gentle treatment of tumors.
The electrodes applied in percutaneous electrical tumor therapy (PET) generates an ion flow of positively charged ions to the cathode and a negative ion flux to the anode.
The change in pH results in depolarization of the cell membranes cialisforlife.com. Resulting hydrochloric acids cause a chemical metabolic disorder in tumor cells triggering programmed cell death. The tumor would then die.
This target-specific and gentle percutaneous electrical tumor therapy (PET) is particularly suitable for the treatment of breast, skin, liver, stomach, lung, lymph, prostate tumors and metastases, which hardly respond to chemotherapy or radiotherapy.
- Breast cancer
- Prostate cancer
- Lymph metastasis / lymphoma
- Primary lung cancer and lung metastases
- Primary hepatic carcinoma and liver metastases / liver cancer
- Primary gastric cancers and gastric metastases / stomach cancer
- All other tumors and metastases in the intra – abdominal
- Skin cancer / skin metastases / skin cancer / cancer black / white cancer